QA: AKCEA THERAPEUTICS INC. in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001662524_2019_AKCEA_THERAPEUTICS_INC.pdf

Logs

error IME and Company effects mismatched for Selling, General and Administrative Expense. IME Effects: 28.7, Company Effect: 28.6 subcommand.report {}
warning Missing logo subcommand.report {}
info original effects; company_effects: -28.65, ime_effects: -28.7 subcommand.report {}
info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Expenses', 'missing_ratio': 0.03141653024973007, 'aggregate_val': 296130000, 'exp_sum': 287110000, 'exp_to_value': {'CostOfGoodsAndServicesSold': 0, 'SellingGeneralAndAdministrativeExpense': 153610000, 'ResearchAndDevelopmentExpense': 130340000, 'remainder_Expenses': 3160000}}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001662524')"}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001662524, AKCEA THERAPEUTICS INC.

  xvar xval
0 AssetsCurrent 267,235,000
1 IntangibleAssetsNetIncludingGoodwill 88,914,000
2 PropertyPlantAndEquipmentNet 5,696,000
3 remainder_Assets 3,416,000
4 LiabilitiesCurrent 80,661,000
5 LiabilitiesNoncurrent 3,434,000
6 remainder_Liabilities 4,442,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 153,610,000
9 ResearchAndDevelopmentExpense 130,340,000
10 remainder_Expenses 12,180,000
11 remainder_Revenues 64,867,000
12 remainder_NetIncome 5,442,000
13 remainder_ComprehensiveNetIncome 127,000
  yvar yval
0 Assets 365,261,000
1 Liabilities 88,537,000
2 Expenses 296,130,000
3 Revenues 64,867,000
4 StockholdersEquity 276,724,000
5 NetIncome -225,821,000
6 ComprehensiveNetIncome -225,757,500
7 BaseVar 410,182,000
8 EconomicCapitalRatio 1.10

Edgar->Model Mapping

Feature Distribution

Change over Time